Hopes rise for breast cancer cure | News | The Sunday Times – The Times

The trial of a new drug to treat an aggressive form of breast cancer has “shattered expectations” raising hopes of a “cure”, according to its maker, AstraZeneca.

The British pharmaceuticals company said three quarters of women in the trial of its new drug, Enhertu, had shown no progression in their disease after 12 months compared with just a third treated with a different medicine.

David Fredrickson, head of oncology at AstraZeneca, said there were tears and cries of surprise when scientists were given the data over a video call last week. “It’s remarkable to hear the oncology community, as they take the data in, say: ‘Is it possible that we could be offering a cure for some women with advanced disease?’”

Breast cancer remains the

Leave a Reply

Your email address will not be published. Required fields are marked *